Third Harmonic Bio, Inc. Board of Directors

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is also developing THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated skin, respiratory, and gastrointestinal conditions. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

Mr. Steven P. Sweeney

Mr. Steven P. Sweeney

Senior Vice President of Development Operations

Ms. Jennifer Dittman

Ms. Jennifer Dittman

Chief Operating Officer

Ommer Chohan

Ommer Chohan

Treasurer & Secretary

Mr. Christopher Murphy

Mr. Christopher Murphy

Chief Financial & Business Officer

Mr. Dennis Dean Ph.D.

Mr. Dennis Dean Ph.D.

Chief Non-Clinical Development Officer

Ms. Julie Person

Ms. Julie Person

Chief Administrative Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.